Emily Weinert

Prof. Emily Weinert

Department of Chemistry, Emory University, Atlanta, GA 30322, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2006 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
EWEmily Weinert
Emily Weinert
RDRuggero Dondi
Ruggero Dondi
SCStefano Colloredo-Melz
Stefano Colloredo-Melz
KFKristen N. Frankenfield
Kristen N. Frankenfield
CMCharles H. Mitchell
Charles H. Mitchell
SRSteven E. Rokita
Steven E. Rokita

1 December 2004 in Molecular Cell
Verified
Journal Article
Closed access
RXRobert X. Xu
Robert X. Xu
MLMillard H. Lambert
Millard H. Lambert
BWBruce B. Wisely
Bruce B. Wisely
EWErin N. Warren
Erin N. Warren
EWEmily Weinert
Emily Weinert
JMJohn T. Moore
John T. Moore

15 July 2003 in Pigment Cell Research
Verified
Journal Article
Closed access
PDF file
YLYan Liu
Yan Liu
VKValerie R. Kempf
Valerie R. Kempf
JNJ. Brian Nofsinger
J. Brian Nofsinger
EWEmily Weinert
Emily Weinert
MRMark Rudnicki
Mark Rudnicki
JSJohn D. Simon
John D. Simon

30 August 2005 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
EWEmily Weinert
Emily Weinert
KFKristen N. Frankenfield
Kristen N. Frankenfield
SRSteven E. Rokita
Steven E. Rokita

23 March 2017 in Frontiers in Microbiology
Verified
Journal Article
Open access
BFBenjamin M. Fontaine
Benjamin M. Fontaine
KNKate Nelson
Kate Nelson
JLJames T. Lyles
James T. Lyles
PJParth B. Jariwala
Parth B. Jariwala
JGJennifer M. García-Rodriguez
Jennifer M. García-Rodriguez
EWEmily Weinert
Emily Weinert
Staphylococcus aureus is a leading cause of hospital-acquired infections. It is listed among the top “serious threats” to human health in the USA, due in large part to rising rates of resistance. Many S. aureus infections are recalcitrant to antibiotic therapy due to their ability to form a biofilm, which acts not only as a physical barrier to antibiotics and the immune system, but results in differences in metabolism that further restricts antibiotic efficacy. Development of a modular strategy to synthesize a library of phenolic glycosides allowed for bioactivity testing and identification of anti-biofilm compounds within an extract of the Elmleaf blackberry (Rubus ulmifolius). Two ellagic acid derivatives, ellagic acid xyloside and ellagic acid rhamnoside, have been identified as components of the Rubus extract. In addition, ellagic acid rhamnoside has been identified as an inhibitor of biofilm formation, with activity comparable to the complex extract 220D-F2 (composed of a mixture of EA-glycosides), and confirmed by confocal laser scanning microscopy analyses.

30 April 2018 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
BFBenjamin M. Fontaine
Benjamin M. Fontaine
KMKevin S. Martin
Kevin S. Martin
JGJennifer M. Garcia-Rodriguez
Jennifer M. Garcia-Rodriguez
CJClaire Jung
Claire Jung
LBLaura Briggs
Laura Briggs
EWEmily Weinert
Emily Weinert
Regulation of nucleotide and nucleoside concentrations is critical for faithful DNA replication, transcription, and translation in all organisms, and has been linked to bacterial biofilm formation. Unusual 2′,3′-cyclic nucleotide monophosphates (2′,3′-cNMPs) recently were quantified in mammalian systems, and previous reports have linked these nucleotides to cellular stress and damage in eukaryotes, suggesting an intriguing connection with nucleotide/nucleoside pools and/or cyclic nucleotide signaling. This work reports the first quantification of 2′,3′-cNMPs in Escherichia coli and demonstrates that 2′,3′-cNMP levels in E. coli are generated specifically from RNase I-catalyzed RNA degradation, presumably as part of a previously unidentified nucleotide salvage pathway. Furthermore, RNase I and 2′,3′-cNMP levels are demonstrated to play an important role in controlling biofilm formation. This work identifies a physiological role for cytoplasmic RNase I and constitutes the first progress toward elucidating the biological functions of bacterial 2′,3′-cNMPs.